[CAS NO. 2060259-60-9]  SRT1720monohydrochloride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2060259-60-9]

Distributor
Catalog
AS942154
Brand
Arctom Scientific
CAS
2060259-60-9

DESCRIPTION [2060259-60-9]

Overview

MDLMFCD22580413
Molecular Weight506.02
Molecular FormulaC25H24ClN7OS
SMILESO=C(C1=NC2=CC=CC=C2N=C1)NC3=C(C=CC=C3)C4=CN5C(CN6CCNCC6)=CSC5=N4.Cl

For research use only. We do not sell to patients.


Summary

SRT 1720 Hydrochloride is a selective activator of SIRT1 with an EC 50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3 [1] .


IC50 & Target

SIRT1

0.10 μM (EC 50 )

SIRT1

0.16 μM (EC1.5)

SIRT2

37 μM (EC1.5)


In Vitro

SRT 1720 effectively decreases the acetylation of p53 in cells even in the absence of SIRT1, and this is attributed to inhibition of histone acetyltransferase p300 [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

SRT 1720 (10, 30, 100 mg/kg, p.o.) treatment significantly reduces fasting blood glucose to near normal levels in Lep ob/ob mice [1] .
SRT 1720 has ability to protect against the negative effects of diet-induced obesity in mice, and has a connection to metabolic adaptation in fatty acid and oxidative metabolism through downstream targets of SIRT1 such as PGC1α and FOXO1 [2] .
SRT 1720 (50-100 mg/kg, p.o.), during emphysema development attenuates elastase-induced airspace enlargement and lung function impairment as well as reduces arterial oxygen saturation in WT mice [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, stored under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)


Solvent & Solubility

In Vitro:

DMSO : 62.5 mg/mL ( 123.51 mM ; Need ultrasonic)

H 2 O : 15.7 mg/mL ( 31.03 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.9762 mL 9.8810 mL 19.7621 mL
5 mM 0.3952 mL 1.9762 mL 3.9524 mL
10 mM 0.1976 mL 0.9881 mL 1.9762 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 0.5% HPMC >> 0.2%Tween80

    Solubility: 10 mg/mL (19.76 mM); Suspened solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (4.11 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (4.11 mM); Clear solution

  • 4.

    Add each solvent one by one: 5% DMSO >> 40% PEG300 >> 5% Tween-80 >> 50% saline

    Solubility: ≥ 1 mg/mL (1.98 mM); Clear solution

  • 5.

    Add each solvent one by one: 5% DMSO >> 95% (20% SBE-β-CD in saline)

    Solubility: ≥ 1 mg/mL (1.98 mM); Clear solution

* All of the co-solvents are available by MCE.